Validation of BRACS to European Portuguese

Translation and Validation of The Boston Residue and Clearance Scale to European Portuguese

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06558435

Enrollment

Registered

2024-08-16

Start date

2023-03-01

Completion date

2023-05-01

Last updated

2024-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deglutition Disorders, Swallowing Disorder, Dysphagia, Oropharyngeal

Keywords

Swallowing Disorders, Dysphagia, Fiberoptic Endoscopic Evaluation of Swallowing

Brief summary

The goal of this observational study is to translate and validate the fiberoptic endoscopic evaluation of swallowing scale The Boston Residue and Clearance Scale - BRACS to European Portuguese

Detailed description

The Boston Residue and Clearance Scale (BRACS) is a multidimensional scale developed and validated to assess the severity of residues observed during fiberoptic endoscopic evaluation of swallowing (FEES). It differs from other FEES residue scales, since it considers all aspects related to pharyngolaryngeal residues, specifically, the location, amount and the patient's clearance ability. The purpose of this study was to translate and cross-culturally adapt the English version of the BRACS into European Portuguese and to investigate the reliability and validity of the translated version of the scale.

Interventions

OTHERFEES

Single group

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* FEES recording that allowed good visualisation of the pharynx and larynx. * FEES recording of patients after head and neck surgery who had anatomical alterations of the structures, but which did not interfere with good visualisation of the residues. * FEES recording of patients with a tracheostomy or under tube feeding.

Exclusion criteria

* FEES recording of patients under 18 years of age.

Design outcomes

Primary

Measure	Time frame	Description
Reliable and validated European Portuguese version of the BRACS	patients with neurological and/or mechanical oropharyngeal dysphagia evaluated FEES up to 3 months after the first symptomatology	Demonstrating the reliability and validity of the Boston Residue and Clearance Scale in diagnosing dysphagia during fiberoptic endoscopic assessment of swallowing examination. BRACS it's an 11-point ordinal residue classification scale that assesses 3 aspects: the amount and location of pharyngolaryngeal residues, the presence of spontaneous swallowing to clear it and the effectiveness of patient's swallowing.

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026